Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females

JAMA Internal Medicine

Volumn 175, Issue 4, 2015, Pages 617-623

  Jena, Anupam B ^a,b,c   Goldman, Dana P ^c,d   Seabury, Seth A ^d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; RECOMBINANT VACCINE; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADOLESCENT DISEASE; AGE; ARTICLE; CHILD; CHLAMYDIASIS; CONTRACEPTIVE BEHAVIOR; FEMALE; GONORRHEA; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VACCINATION; WART VIRUS; CHLAMYDIA INFECTIONS; FACTUAL DATABASE; HERPES GENITALIS; HIV INFECTIONS; INCIDENCE; INSURANCE; LONGITUDINAL STUDY; SEXUALLY TRANSMITTED DISEASES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; UNSAFE SEX;

ADOLESCENT; CHILD; CHLAMYDIA INFECTIONS; DATABASES, FACTUAL; FEMALE; GONORRHEA; HERPES GENITALIS; HIV INFECTIONS; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; LONGITUDINAL STUDIES; PAPILLOMAVIRUS VACCINES; SEXUALLY TRANSMITTED DISEASES; SYPHILIS; UNITED STATES; UNSAFE SEX;

EID: 84928181816     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.7886     Document Type: Article

References (41)

1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819.
2. Centers for Disease Control and Prevention. Cervical cancer statistics. 2014. http://www.cdc.gov/cancer/cervical/statistics/. Accessed July 7, 2014.
3. Arbyn M, Castellsagué X, de Sanjosé S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22(12):2675-2686.
4. Food and Drug Administration. Product approval information: human papillomavirus quadrivalent (types 6, 11, 16, 18) vaccine, recombinant. 2006. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM094042. Accessed July 7, 2014.
5. Food and Drug Administration. Product approval information: human papillomavirus bivalent (types 16 and 18) vaccine, recombinant. 2009. http://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm186957.htm. Accessed July 7, 2014.
6. Markowitz LE, Dunne EF, Saraiya M, et al Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWRRecomm Rep. 2014;63(RR-05):1-30.
7. Stokley S, Jeyarajah J, Yankey D, et al Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620-624.
8. Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health. 2008;43(4)(suppl):S61-S67.
9. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine. 2011;29(17):3138-3143.
10. Patel DA, Zochowski M, Peterman S, Dempsey AF, Ernst S, Dalton VK. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health. 2012;60(2):151-161.
11. Sundaram SS, Roberts C, Rowen D, Patel R. Parental attitudes towards the human papillomavirus vaccine in ethnic minorities. Int J STD AIDS. 2010;21(6):449.
12. Liddon NC, Hood JE, Leichliter JS. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women. Vaccine. 2012;30(16):2676-2682.
13. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008;111(5):1103-1110.
14. Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007;25(11):1945-1952.
15. Charo RA. Politics, parents, and prophylaxis - mandating HPV vaccination in the United States. N Engl J Med. 2007;356(19):1905-1908.
16. Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439-1445.
17. Kahn JA, Zimet GD, Bernstein DI, et al. Pediatricians' intention to administer human papillomavirus vaccine. J Adolesc Health. 2005;37(6):502-510.
18. Waller J, Marlow LA, Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1257-1261.
19. Williams K, Forster A, Marlow L, Waller J. Attitudes towards human papillomavirus vaccination: a qualitative study of vaccinated and unvaccinated girls aged 17-18 years. J Fam Plann Reprod Health Care. 2011;37(1):22-25.
20. Schuler CL, Reiter PL, Smith JS, Brewer NT. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect. 2011;87(4):349-353.
21. Forster A, Wardle J, Stephenson J, Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun. 2010;15(2):205-217.
22. Ferris DG, Cromwell L, Waller JL, Horn L. Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J Low Genit Tract Dis. 2010;14(3):179-184.
23. Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors associated with intention to vaccinate a daughter against HPV. J Pediatr Adolesc Gynecol. 2011;24(3):166-171.
24. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med. 2012;42(1):44-52.
25. Mullins TL, Zimet GD, Rosenthal SL, et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med. 2012;166(1):82-88.
26. Bowyer HL, Dodd RH, Marlow LA, Waller J. Association between human papillomavirus vaccine status and other cervical cancer risk factors. Vaccine. 2014;32(34):4310-4316.
27. Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics. 2012;130(5):798-805.
28. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2012. Atlanta, GA: US Dept of Health and Human Services; 2014.
29. Jena AB, Goldman DP, Kamdar A, Lakdawalla DN, Lu Y. Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med. 2010;153(1):1-7.
30. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288(14):1733-1739.
31. Karaca-Mandic P, Jena AB, Joyce GF, Goldman DP. Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA. 2012;307(12):1284-1291.
32. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350.
33. Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory Methods. 1980;9(10):1043-1069.
34. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 Years - United States, 2012. 2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm#Tab1. Accessed July 7, 2014.
35. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme. BMJ. 2013;346:f2032.
36. National HPV Vaccination Program Register. HPV vaccination coverage by dose number (Australia) for females by age group in mid 2012. 2014. http://www.hpvregister.org.au/research/coverage-data/coverage-by-dose-2012. Accessed July 16, 2014.
37. Daley MF, Liddon N, Crane LA, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118(6):2280-2289.
38. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425-433.
39. Perkins RB, Clark JA, Apte G, et al. Missed opportunities for HPV vaccination in adolescent girls. Pediatrics. 2014;134(3):e666-e674.
40. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475-480.
41. Reiter PL, Cates JR, McRee AL, et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis. 2010;37(9):549-556.